Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy · Delayed Price · Currency is EUR 51.45
+0.10 (0.19%)
Jul 27, 2026, 5:36 PM CET
BIT:REC Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 713.42 | 2,618 | 2,342 | 2,082 | 1,853 | 1,580 |
Revenue Growth | -70.44% | 11.82% | 12.45% | 12.36% | 17.29% | 9.06% |
Gross Profit Gross Profit Growth | 510.83 | 1,788 | 1,600 | 1,423 | 1,287 | 1,152 |
Operating Income Operating Income Growth | 229.6 | 670.81 | 638.86 | 558.01 | 437.33 | 490.19 |
Net Income Net Income Growth | 153.06 | 443.62 | 416.51 | 389.21 | 312.34 | 385.97 |
Earnings Per Share EPS Growth | 2.25 | 2.12 | 1.99 | 1.86 | 1.49 | 1.05 |
EPS Growth | 12.81% | 6.48% | 7.04% | 24.57% | 42.56% | -38.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Specialty & Primary Care Specialty & Primary Care Growth | 1,478 | 1,537 | 1,508 | 1,368 | 1,258 | 1,196 |
Rare Diseases Rare Diseases Growth | 1,081 | 1,081 | 833.86 | 714.72 | 595.79 | 383.85 |
Revenue (Total) Revenue (Total) Growth | 2,618 | 2,618 | 2,342 | 2,082 | 1,853 | 1,580 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 380.47 | 428.82 | 322.42 | 221.81 | 284.73 | 244.58 |
Total Debt Total Debt Growth | 2,367 | 2,467 | 2,484 | 1,809 | 1,717 | 992.19 |
Net Cash (Debt) Net Cash Growth | -1,986 | -2,039 | -2,162 | -1,587 | -1,432 | -747.61 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.69 | -9.92 | -10.48 | -7.72 | -6.96 | -3.63 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 534.98 | 596.9 | 569.92 | 485.32 | 461.69 | 491.65 |
Capital Expenditures CapEx Growth | -44.66 | -39.44 | -36.65 | -29.69 | -23.89 | -21.85 |
Free Cash Flow Free Cash Flow Growth | 490.32 | 557.45 | 533.27 | 455.63 | 437.8 | 469.8 |
Free Cash Flow Growth | -36.19% | 4.54% | 17.04% | 4.07% | -6.81% | 22.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.60% | 68.27% | 68.34% | 68.32% | 69.42% | 72.93% |
Operating Margin | 32.18% | 25.62% | 27.28% | 26.80% | 23.60% | 31.02% |
Pretax Margin | 28.14% | 22.20% | 23.37% | 23.58% | 21.66% | 29.32% |
Profit Margin | 7.74% | 16.94% | 17.79% | 18.69% | 16.85% | 24.43% |
FCF Margin | 68.73% | 21.29% | 22.77% | 21.88% | 23.62% | 29.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.340 | 1.340 | 1.270 | 1.200 | 1.150 | 1.100 |
Dividend Per Share Growth | 5.51% | 5.51% | 5.83% | 4.35% | 4.54% | 4.76% |
Dividend Yield | 2.61% | 2.68% | 2.43% | 2.45% | 2.89% | 1.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.82 | 22.89 | 25.40 | 26.24 | 25.94 | 53.91 |
Forward PE | 19.69 | 19.36 | 20.92 | 22.69 | 20.55 | 28.63 |
P/FCF Ratio | 21.35 | 17.79 | 19.57 | 22.08 | 18.18 | 24.76 |
PS Ratio | 3.95 | 3.79 | 4.46 | 4.83 | 4.30 | 7.36 |